Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 9:18:1362494.
doi: 10.3389/fncel.2024.1362494. eCollection 2024.

Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives

Affiliations
Review

Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives

Yating Gao et al. Front Cell Neurosci. .

Abstract

Spinal cord injury (SCI) disrupts nerve pathways and affects sensory, motor, and autonomic function. There is currently no effective treatment for SCI. SCI occurs within three temporal periods: acute, subacute, and chronic. In each period there are different alterations in the cells, inflammatory factors, and signaling pathways within the spinal cord. Many biomaterials have been investigated in the treatment of SCI, including hydrogels and fiber scaffolds, and some progress has been made in the treatment of SCI using multiple materials. However, there are limitations when using individual biomaterials in SCI treatment, and these limitations can be significantly improved by combining treatments with stem cells. In order to better understand SCI and to investigate new strategies for its treatment, several combination therapies that include materials combined with cells, drugs, cytokines, etc. are summarized in the current review.

Keywords: biomaterial scaffolds; cell transplantation; spinal cord injury; spinal cord repair; stem cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Pathophysiologic mechanisms of SCI. Acute phase: exhibits hematoma formation, Wallerian degeneration of distal axons with demyelination reaction, ROS production, inflammation occurs, ionic imbalance, macrophages phagocytose debris, astrocytes migrate toward the center of the lesion and encapsulate the damaged tissues, microglia are also activated and change their morphology, fibroblasts induce fibroblast reaction, and a large number of fibroblasts are deposited around the core of the lesion. Subacute phase: astrocytes form a glial scar and debris is further engulfed. Chronic phase: progressive generation of empty capsule cavities, myelin debris, deposition of GSPGs and scarred astrocytes.
Figure 2
Figure 2
Combinations of cells and capillary scaffolding. SCI creates cavities that impede axonal signaling. Alginate capillary hydrogels have well-aligned channels that propel cell growth in specific directions. When stem cells derived from embryonic cells are implanted into the alginate hydrogel, they occupy the voids and promote axonal regeneration. Stem cells are able to establish synapse-like connections between host axons and neurons formed by the stem cells within the alginate hydrogel channels, thus promoting spinal cord regeneration (Szymoniuk et al., 2022).

Similar articles

Cited by

References

    1. Abbas W. A., Ibrahim M. E., El-Naggar M., Abass W. A., Abdullah I. H., Awad B. I., et al. . (2020). Recent advances in the regenerative approaches for traumatic spinal cord injury: materials perspective. ACS Biomater Sci. Eng. 6, 6490–6509. doi: 10.1021/acsbiomaterials.0c01074, PMID: - DOI - PubMed
    1. Adams K. L., Gallo V. (2018). The diversity and disparity of the glial scar. Nat. Neurosci. 21, 9–15. doi: 10.1038/s41593-017-0033-9, PMID: - DOI - PMC - PubMed
    1. Anjum A., Yazid M. D., Fauzi Daud M., Idris J., Ng A. M. H., Selvi Naicker A., et al. . (2020). Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int. J. Mol. Sci. 21:7533. doi: 10.3390/ijms21207533, PMID: - DOI - PMC - PubMed
    1. Attia N., Mashal M. (2021). Mesenchymal stem cells: the past present and future. Adv. Exp. Med. Biol. 1312, 107–129. doi: 10.1007/5584_2020_595, PMID: - DOI - PubMed
    1. Bacakova L., Zarubova J., Travnickova M., Musilkova J., Pajorova J., Slepicka P., et al. . (2018). Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnol. Adv. 36, 1111–1126. doi: 10.1016/j.biotechadv.2018.03.011, PMID: - DOI - PubMed

LinkOut - more resources